NIH awards $40M for Alzheimer's disease drug trials, research

NIH Director Dr. Francis Collins tapped the budgets of all 27 NIH institutes to raise $40 million for several Alzheimer's disease research projects, and the National Institute on Aging provided another $5 million. "Obviously, this is high-risk research, but goodness, the stakes are so high that we felt we had to go forward even in the face of the most difficult budget environment that anyone can remember in the NIH," Collins said. A $33.2 million grant will go toward a clinical trial of a drug in people genetically predisposed to Alzheimer's disease but with no symptoms, and $1.5 million will fund a trial of three anti-amyloid drugs in people with rare gene mutations related to early-onset Alzheimer's.

View Full Article in:

Bloomberg · New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC